As 2023 draws to a close, the pharma industry finds itself at an inflection point. On the one hand, stubbornly high inflation rates, a dearth of talent, supply chain hurdles, and a more challenging regulatory climate threaten profitability. But on the other, the rapid advances in areas ranging from cell and gene therapy and IT…
Exploring pharma applications of Xilinx’s adaptive system-on-modules
Earlier this year, Xilinx (San Jose, Calif.) launched its Kria line of adaptive system-on-modules (SOMs) for a host of AI applications, including in factory and healthcare environments. In terms of the former, the SOMs target digital twin, predictive maintenance and defect detection applications. SOMs, which are small embedded boards about the size of a credit…
Pharma’s been slow to adopt Industry 4.0 — but that could change
The pharma industry has been relatively slow to embrace concepts such as Industry 4.0, but COVID-19 is serving as a catalyst for sweeping changes within the industry. The philosophy has roots in a German framework that prioritizes digitization to drive manufacturing efficiency, promising that cyber-physical systems will usher in the next industrial revolution. The Industry…